Delivery Order HHSO100201200013I-HHSO10033004T
Award Date 4/26/13
Potential Completion Date 7/25/13
Potential Value $534K
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27709, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order award to Glaxosmithkline, LLC under the Pandemic Influenza Preparedness and Response 2012-2016 indefinite delivery/indefinite quantity (IDIQ) contract with the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (HHS ASPR). The $2,812,228.00 fixed-price order is for the production of clinical lots of a CGMP (current good manufacturing practice) influenza vaccine. This supports the Acquisition of Medical...
- This is a delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) to GlaxoSmithKline, LLC, a pharmaceutical company, under the Pandemic Influenza Preparedness and Response 2012-2016 contract. The contract is for the production of non-GMP influenza vaccine plots at a firm fixed price of $149,412.00. The award supports ASPR's broader efforts for pandemic influenza preparedness and response, including disease...
- This is a firm fixed price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Glaxosmithkline, LLC to provide the acquisition of egg-based influenza master and working seed lots derived from a specific candidate vaccine virus, as well as fill-finish of any existing egg-based influenza vaccines. The order has a ceiling value of $1,650,050.61 and a completion date of February 21, 2026. No set-aside designation was used....
- This $563,504 firm fixed price delivery order was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The order is part of the Pandemic Influenza Preparedness and Response 2016-2021 indefinite delivery, indefinite quantity (IDIQ) contract and does not have a...
- This is a $499,100 firm fixed price delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Glaxosmithkline, LLC. The order is for pharmaceutical goods and services under the Pandemic Influenza Preparedness and Response 2016-2021 multiple award contract. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, provides a range of products to U.S. government agencies including influenza and hepatitis...
- This is a $2,100,000.00 firm fixed price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency, to Medimmune LLC for the funding of CGMP influenza vaccine optimized master and working seed lot production. The contract is part of the Pandemic Influenza Preparedness and Response 2012-2016 contract vehicle. There is no set-aside designation for this award. The contract has an ultimate completion date of October 31, 2013.
- This is a $2,603,484.86 firm fixed price purchase order awarded by the U.S. Department of Health and Human Services to Glaxosmithkline, LLC for the supply of influenza vaccine for the 2015-2016 season. The contract did not have a set-aside designation. Glaxosmithkline, a pharmaceutical company that provides vaccines and other products to federal agencies, was the prime contractor on this award. The contract was performed at Glaxosmithkline's facilities in Research Triangle Park, North...
- This is a $69,857,670.45 firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, doing business as Glaxosmithkline, for 2016 pandemic influenza preparedness efforts. The contract has a completion date of February 28, 2017 and was awarded on December 18, 2015. There was no set-aside designation used. Glaxosmithkline is a pharmaceutical company that provides vaccines, antiviral medications, and other products to various federal agencies,...
- This federal contract award provides $4,002,243.15 in funding to Glaxosmithkline, LLC, a pharmaceutical company, for the acquisition of medical countermeasures (MCMs) and pandemic influenza preparedness and response under a new solicitation from the Department of Health and Human Services Biomedical Advanced Research and Development Authority (HHS-BARDA). The contract is a delivery order issued under the Pandemic Influenza Preparedness and Response 2012-2016 indefinite delivery, indefinite...
- This is a delivery order issued under the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) Pandemic Influenza Preparedness and Response 2016-2021 contract vehicle. The $2,064,652.60 firm fixed price contract was awarded to Glaxosmithkline, LLC to provide a range of pharmaceutical goods and services, including influenza vaccines, antiviral medications, vaccine adjuvants, and COVID-19 treatments. Glaxosmithkline, a foreign-owned...